Functional Analysis of Leishmania Cyclopropane Fatty Acid Synthetase
Open Access
- 10 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12), e51300
- https://doi.org/10.1371/journal.pone.0051300
Abstract
The single gene encoding cyclopropane fatty acid synthetase (CFAS) is present in Leishmania infantum, L. mexicana and L. braziliensis but absent from L. major, a causative agent of cutaneous leishmaniasis. In L. infantum, usually causative agent of visceral leishmaniasis, the CFAS gene is transcribed in both insect (extracellular) and host (intracellular) stages of the parasite life cycle. Tagged CFAS protein is stably detected in intracellular L. infantum but only during the early log phase of extracellular growth, when it shows partial localisation to the endoplasmic reticulum. Lipid analyses of L. infantum wild type, CFAS null and complemented parasites detect a low abundance CFAS-dependent C19Δ fatty acid, characteristic of a cyclopropanated species, in wild type and add-back cells. Sub-cellular fractionation studies locate the C19Δ fatty acid to both ER and plasma membrane-enriched fractions. This fatty acid is not detectable in wild type L. major, although expression of the L. infantum CFAS gene in L. major generates cyclopropanated fatty acids, indicating that the substrate for this modification is present in L. major, despite the absence of the modifying enzyme. Loss of the L. infantum CFAS gene does not affect extracellular parasite growth, phagocytosis or early survival in macrophages. However, while endocytosis is also unaffected in the extracellular CFAS nulls, membrane transporter activity is defective and the null parasites are more resistant to oxidative stress. Following infection in vivo, L. infantum CFAS nulls exhibit lower parasite burdens in both the liver and spleen of susceptible hosts but it has not been possible to complement this phenotype, suggesting that loss of C19Δ fatty acid may lead to irreversible changes in cell physiology that cannot be rescued by re-expression. Aberrant cyclopropanation in L. major decreases parasite virulence but does not influence parasite tissue tropism.Keywords
This publication has 62 references indexed in Scilit:
- Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistanceGenome Research, 2011
- Chromosome and gene copy number variation allow major structural change between species and strains of LeishmaniaGenome Research, 2011
- Cathepsin B-like and cell death in the unicellular human pathogen LeishmaniaCell Death & Disease, 2010
- N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral LeishmaniasisJournal of Molecular Biology, 2010
- Mycolic Acid Cyclopropanation is Essential for Viability, Drug Resistance, and Cell Wall Integrity of Mycobacterium tuberculosisCell Chemical Biology, 2009
- MAM: more than just a housekeeperTrends in Cell Biology, 2009
- The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasiMolecular and Biochemical Parasitology, 2008
- Comparative genomics: From genotype to disease phenotype in the leishmaniasesInternational Journal for Parasitology, 2007
- Comparative genomic analysis of three Leishmania species that cause diverse human diseaseNature Genetics, 2007
- Trypanosoma bruceiARF1 Plays a Central Role in Endocytosis and Golgi–Lysosome TraffickingMolecular Biology of the Cell, 2007